Cellular and molecular mechanisms of metformin: an overview
Open accessThe DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Abstract
Considerable efforts have been made since the 1950s to better understand the cellular and molecular mechanisms of action of metformin, a potent antihyperglycaemic agent now recommended as the first-line oral therapy for T2D (Type 2 diabetes). The main effect of this drug from the biguanide family is to acutely decrease hepatic glucose production, mostly through a mild and transient inhibition of the mitochondrial respiratory chain complex I. In addition, the resulting decrease in hepatic energy status activates AMPK (AMP-activated protein kinase), a cellular metabolic sensor, providing a generally accepted mechanism for the action of metformin on hepatic gluconeogenesis. The demonstration that respiratory chain complex I, but not AMPK, is the primary target of metformin was recently strengthened by showing that the metabolic effect of the drug is preserved in liver-specific AMPK-deficient mice. Beyond its effect on glucose metabolism, metformin has been reported to restore ovarian function in PCOS (polycystic ovary syndrome), reduce fatty liver, and to lower microvascular and macrovascular complications associated with T2D. Its use has also recently been suggested as an adjuvant treatment for cancer or gestational diabetes and for the prevention in pre-diabetic populations. These emerging new therapeutic areas for metformin will be reviewed together with recent findings from pharmacogenetic studies linking genetic variations to drug response, a promising new step towards personalized medicine in the treatment of T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In PCOS, metformin reduces insulin resistance and inhibits ovarian androgen production via effects on steroidogenic acute regulatory protein and 17alphahydroxylase (Diamanti-Kandarakis et al. , 2010; Viollet et al. , 2012).”
From Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis (2015) · cites this paper as Viollet et al., 2012
The cited source says what the claim attributes to it.
In the citing paper
“a drug that is currently being used to treat type II diabetic patients, metformin [74], can activate AMPK”
From Senescence of T Lymphocytes: Implications for Enhancing Human Immunity (2016) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“Given the evidence that metformin acts through the mitochondrial electron transport chain (ETC) by inhibiting complex I(46, 210–212) (Figure 8)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [46]
In the citing paper
“By far the most important mechanism is the reduction in hepatic glucose production that is considered mediated by the activation of the global energy sensor in cells, adenosine monophosphate-activated protein kinase (AMPK) (Figure 1).(46)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 4×
“Thus, AMPK activation by metformin induces the phosphorylation and inactivation of acetyl CoA carboxylase (ACC), an important rate-controlling enzyme for the synthesis of malonylCoA, which is both a critical precursor for the biosynthesis of fatty acids and a potent inhibitor of mitochondrial fatty acid oxidation [17].”
BackgroundInfluentialHyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · cited 1×
“Furthermore, the authors found a doseresponse relationship between duration of exposure to metformin and cancer incidence [106].”
BackgroundGiovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950 · cited 25×
“Metformin most likely does not directly activate either LKB1 or AMPK as the drug does not influence the phosphorylation of AMPK by LKB1 in cell-free assay [21].”
BackgroundInfluential
Cited by
Items 701–800 of 1,001
UCP2 regulates cholangiocarcinoma cell plasticity via mitochondria-to-AMPK signals
Yu, J., Shi, L., Shen, X., & Zhao, Y. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.05.017 · Cited by 30
Recent research and clinical progress of CTLA-4-based immunotherapy for breast cancer
Zhang, H., Mi, J., Qi, X., Cao, W., Song, C., Zhang, N., & Yuan, C. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1256360 · Cited by 31
Hyperlactataemia and clinical severity of acute metformin overdose
Mcnamara, K., & Isbister, G. K. (2015) · Internal Medicine Journal · doi:10.1111/imj.12713 · Cited by 27
Ai, Q., Jing, Y., Jiang, R., Lin, L., Dai, J., Che, Q., Zhou, D., Jia, M., Wan, J., & Zhang, L. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.04.028 · Cited by 29
Senjoti, F. G., Mahmood, S., Jaffri, J. M., & Mandal, U. K. (2016) · PubMed Central · Cited by 40
Kuo, Y., Lin, C., & Shih, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060872 · Cited by 27
Pleiotropic Effects of Biguanides on Mitochondrial Reactive Oxygen Species Production
Pecinová, A., Drahota, Z., Kovalcikova, J., Kovářová, N., Pecina, P., Alán, L., Zima, M., Houštěk, J., & Mráček, T. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7038603 · Cited by 29
Cao, H., Liao, S., Zhong, W., Xiao, X., Zhu, J., Li, W., Wu, X., & Feng, Y. (2017) · Molecules · doi:10.3390/molecules22101752 · Cited by 27
Rajaei, E., Haybar, H., Mowla, K., & Zayeri, Z. D. (2018) · Current Rheumatology Reviews · doi:10.2174/1573397114666180717145745 · Cited by 30
Assatse, Y. T., Ejuh, G. W., Tchoffo, F., & Ndjaka, J. M. B. (2019) · Chinese Journal of Physics · doi:10.1016/j.cjph.2019.01.014 · Cited by 27
Pennanen, P. T., Syvälä, H., Bläuer, M., Savinainen, K., Ylikomi, T. J., Tammela, T. L. J., & Murtola, T. J. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.06.036 · Cited by 27
Acid-base and electrolyte disorders associated with the use of antidiabetic drugs
Filippatos, T. D., Tzavella, E., Rizos, C. V., Elisaf, M., & Liamis, G. L. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1361400 · Cited by 33
Yang, J., Zhuang, C., Lin, Y., Yu, Y., Zhou, C.-C., Zhang, C., Zhu, Z., Qian, C., Zhou, Y., Zheng, W., et al. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4360 · Cited by 26
Toppila, M., Ranta‐aho, S., Kaarniranta, K., Hytti, M., & Kauppinen, A. (2024) · Cells · doi:10.3390/cells13171433 · Cited by 27
Rahimi, S., Ferdowsi, A., & Siahposht-Khachaki, A. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00594-3 · Cited by 27
Mishra, N., Verma, R., & Jadaun, P. (2022) · Cureus · doi:10.7759/cureus.21781 · Cited by 31
RetractedHypothesis: Metformin is a potential reproductive toxicant
Petersson, M. T., Skakkebæk, N. E., Mathiesen, E. R., Kristensen, D. M., Kjær, K. H., Andersson, A., & Lindahl‐Jacobsen, R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1000872 · Cited by 26
The double trouble of metabolic diseases: the diabetes–cancer link
Tudzarova, S., & Osman, M. A. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-11-1550 · Cited by 26
Introduction to Personalized Medicine in Diabetes Mellitus
Glauber, H. S., Rishe, N. D., & Karnieli, E. (2014) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10136 · Cited by 31
Metformin protects against gentamicin-induced hair cell death in vitro but not ototoxicity in vivo
Oishi, N., Kendall, A., & Schacht, J. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.09.028 · Cited by 26
Proteomic analysis of liver mitochondria of apolipoprotein E knockout mice treated with metformin
Stachowicz, A., Suski, M., Olszanecki, R., Madej, J., Okoń, K., & Korbut, R. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.08.015 · Cited by 26
Ju, K. D., Kim, H. J., Tsogbadrakh, B., Lee, J., Ryu, H., Cho, E. J., Hwang, Y., Kim, K., Yang, J., Ahn, C., et al. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00204.2015 · Cited by 27
Sato, A., Asano, T., Okubo, K., Isono, M., & Asano, T. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504017x14957929842972 · Cited by 26
Gelin, L., Li, J., Corbin, K. L., Jahan, I., & Nunemaker, C. S. (2018) · Journal of Diabetes Research · doi:10.1155/2018/9163052 · Cited by 26
Mechanisms of beneficial effects of metformin on fatty acid-treated human islets
Cen, J., Sargsyan, E., Forslund, A. H., & Bergsten, P. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0304 · Cited by 28
Metformin is associated with a lower risk of non-Hodgkin lymphoma in patients with type 2 diabetes
Tseng, C. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.05.002 · Cited by 26
Wattamwar, T., Mungantiwar, A., Gujar, S., & Pandita, N. S. (2020) · Journal of Chromatography B · doi:10.1016/j.jchromb.2020.122281 · Cited by 26
Tseng, C. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.592901 · Cited by 27
Tulipano, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313068 · Cited by 30
Metformin and risk of chronic obstructive pulmonary disease in diabetes patients
Tseng, C. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.05.001 · Cited by 27
Emerging uncertainty on the anti-aging potential of metformin
Keys, M. T., Hallas, J., Miller, R. A., Suissa, S., & Christensen, K. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102817 · Cited by 29
Dual inhibiting OCT4 and AKT potently suppresses the propagation of human cancer cells
Li, W., Zhou, Y., Zhang, X., Yang, Y., Dan, S., Su, T., She, S., Dong, W., Zhao, Q. D., Jia, J., et al. (2017) · Scientific Reports · doi:10.1038/srep46246 · Cited by 26
Borah, B., & Devi, T. G. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.128819 · Cited by 25
Saha, A., Samadder, A., & Nandi, S. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666221201150933 · Cited by 30
State‐of‐the‐art therapies for fragile X syndrome
Protic, D. D., & Hagerman, R. J. (2024) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.15885 · Cited by 26
Wahab, N. A. A., Abdullah, N., & Aminudin, N. (2014) · BioMed Research International · doi:10.1155/2014/131607 · Cited by 25
Naicker, N., Nagiah, S., Phulukdaree, A., & Chuturgoon, A. A. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0081 · Cited by 35
Forcato, S., Novi, D. R. B. S., Costa, N. O., Borges, L. I., de Góes, M. L. M., Ceravolo, G. S., & Gerardin, D. C. C. (2017) · Reproductive Toxicology · doi:10.1016/j.reprotox.2017.08.023 · Cited by 25
Sarmiento-Ortega, V. E., Brambila, E., Flores-Hernández, J. Á., Díaz, A., Peña‐Rosas, U., Moroni-González, D., Aburto-Luna, V., & Treviño, S. (2018) · Toxics · doi:10.3390/toxics6030055 · Cited by 25
SHIPping out diabetes—Metformin, an old friend among new SHIP2 inhibitors
Lehtonen, S. H. (2019) · Acta Physiologica · doi:10.1111/apha.13349 · Cited by 27
Metformin usage and the risk of colorectal cancer: a national cohort study
Lee, J., Choi, E.-A., Kim, Y.-S., Kim, Y., You, H., Han, Y.-E., Kim, H.-S., Bae, Y., Kim, J., & Kang, H. (2020) · International Journal of Colorectal Disease · doi:10.1007/s00384-020-03765-x · Cited by 26
Harishankar, M. K., Somasundaram, L., Sujeevan, S., ArulJothi, K. N., Macrin, D., & Devi, A. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.06.013 · Cited by 26
Diabetes mellitus: The pathophysiology as a canvas for management elucidation and strategies
Iheagwam, F. N., & Iheagwam, O. T. (2025) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2025.100351 · Cited by 32
Maan, P., Gautam, R., Vasudevan, S., Menon, G. R., Arora, A., Nair, A., Jabbar, P. K., & Arora, T. K. (2025) · Pharmaceuticals · doi:10.3390/ph18050680 · Cited by 28
Diabetes, insulin use, smoking, and pancreatic cancer mortality in Taiwan
Tseng, C. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0471-0 · Cited by 24
Pra, A. D., Locke, J. A., Borst, G. R., Supiot, S., & Bristow, R. G. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00024 · Cited by 26
Asadian, S., Alibabrdel, M., Daei, N., Cheraghi, H., Jafari, S. M., Noshadirad, E., Jabarpour, M., Siavashi, V., & Nassiri, S. M. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27985 · Cited by 24
Repurposing nonantibiotic drugs as antibacterials
Thakare, R., Kaul, G., Shukla, M., Kesharwani, P., Srinivas, N., Dasgupta, A., & Chopra, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818480-6.00005-9 · Cited by 27
Carvalho‐e‐Silva, A. P., Harmer, A. R., Ferreira, M. L., & Ferreira, P. H. (2021) · European Journal of Pain · doi:10.1002/ejp.1747 · Cited by 24
Pietrzyk, N., Zakłos‐Szyda, M., Koziołkiewicz, M., & Podsędek, A. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104437 · Cited by 25
Alhourani, A. H., Tidwell, T., Bokil, A. A., Røsland, G. V., Tronstad, K. J., Søreide, K., & Hagland, H. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-89861-6 · Cited by 24
Klose, K., Packeiser, E., Müller, P., Granados-Soler, J. L., Schille, J. T., Goericke‐Pesch, S., Kietzmann, M., Escobar, H. M., & Nolte, I. J. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257403 · Cited by 29
Ding, Y., Fan, Y., Li, X., Wang, Y., Wang, J., & Tian, L. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-01006-0 · Cited by 24
Vieira, Y., Ribeiro, T. H., Leichtweis, J., Dotto, G. L., Foletto, E. L., Georgin, J., Franco, D. S. P., & Lima, E. C. (2023) · Journal of Water Process Engineering · doi:10.1016/j.jwpe.2023.103943 · Cited by 28
Rahman, N., Bharti, M., Nasir, M., & Azmi, S. N. H. (2023) · Next Materials · doi:10.1016/j.nxmate.2023.100046 · Cited by 24
Shin, D., Cho, Y. M., Lee, S., Lim, K. S., Kim, J.-A., Ahn, J.-Y., Cho, J., Lee, H., Jang, I., & Yu, K. (2014) · Clinical Drug Investigation · doi:10.1007/s40261-014-0184-3 · Cited by 24
Nagasawa, H., Narise, K., Okuda, K., Hirayama, T., & Enomoto, Y. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s59679 · Cited by 30
Canonical and new generation anticancer drugs also target energy metabolism
Rodríguez‐Enríquez, S., Gallardo‐Pérez, J. C., Hernández‐Reséndiz, I., Marín‐Hernández, Á., Pacheco-Velázquez, S. C., López‐Ramírez, S. Y., Rumjanek, F. D., & Moreno‐Sánchez, R. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1246-2 · Cited by 25
Singh, J., Olle, B., Suhail, H., Felicella, M. M., & Giri, S. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13562 · Cited by 24
Ji, L., Pan, C. ‐., Lu, J. ‐., Li, H., Zhu, D., Li, Q., Li, Q., Peng, Y.-L., Tian, H., Yao, C., et al. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12667 · Cited by 24
Raj, J., & Uppuluri, K. B. (2015) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/585 · Cited by 24
Fortun, S., Beauclair, P., & Schmitzer, A. R. (2017) · RSC Advances · doi:10.1039/c7ra01197k · Cited by 24
Suzuki, Y., Enokido, Y., Yamada, K., Inaba, M., Kuwata, K., Hanada, N., Morishita, T., Mizuno, S., & Wakamatsu, N. (2017) · Oncotarget · doi:10.18632/oncotarget.17566 · Cited by 27
Chiew, A. L., Wright, D. F. B., Dobos, N. M., McArdle, K., Mostafa, A., Newth, A., Roberts, M. S., & Isbister, G. K. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13582 · Cited by 25
Jelić-Knezović, N., Galijašević, S., Lovrić, M., Vasilj, M., Selak, S., & Mikulić, I. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0577-7776 · Cited by 24
CaMKK2 Signaling in Metabolism and Skeletal Disease: a New Axis with Therapeutic Potential
Williams, J. N., & Sankar, U. (2019) · Current Osteoporosis Reports · doi:10.1007/s11914-019-00518-w · Cited by 25
Saif, M. W., Rajagopal, S., Caplain, J., Grimm, E. A., Serebrennikova, O. B., Das, M., Tsichlis, P. N., & Martell, R. E. (2019) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-019-03967-3 · Cited by 24
Metformin Effect on Endocan Biogenesis in Human Endothelial Cells Under Diabetic Condition
Zolali, E., Rezabakhsh, A., Nabat, E., Jaberi, H., Rahbarghazi, R., & Garjani, A. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.08.012 · Cited by 25
Petchsila, K., Prueksaritanond, N., Insin, P., Yanaranop, M., & Chotikawichean, N. (2020) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2020.21.3.733 · Cited by 24
Diabetes, Metformin, and Lung Cancer: Retrospective Study of the Korean NHIS-HEALS Database
Kim, J., Hyun, H.-J., Choi, E.-A., Yoo, J. W., Lee, S., Jeong, N., Shen, J. J., You, H., Kim, Y.-S., & Kang, H. (2020) · Clinical Lung Cancer · doi:10.1016/j.cllc.2020.04.001 · Cited by 25
Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
Singh, M., Nicol, A. T., DelPozzo, J., Wei, J., Singh, M., Nguyen, T., Kobayashi, S., & Liang, Q. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.839644 · Cited by 24
Tzeng, H., & Chyuan, I. (2021) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.03.019 · Cited by 29
Hidradenitis suppurativa: a review of current treatment options
Lewandowski, M., Świerczewska, Z., & Barańska‐Rybak, W. (2022) · International Journal of Dermatology · doi:10.1111/ijd.16115 · Cited by 24
Diabetes and COVID-19: The potential role of mTOR
Pinchera, B., Scotto, R., Buonomo, A. R., Zappulo, E., Stagnaro, F. M., Gallicchio, A., Viceconte, G., Sardanelli, A., Mercinelli, S., Villari, R., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109813 · Cited by 23
Dahabiyeh, L. A., Mujammami, M. H., AlMalki, R. H., Arafat, T., Benabdelkamel, H., Alfadda, A. A., & Rahman, A. M. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911478 · Cited by 24
Barnett, A. H., Charbonnel, B. H., Moses, R. G., & Kalra, S. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1081589 · Cited by 26
Matsumoto, T., Alves-Lopes, R., Taguchi, K., Kobayashi, T., & Tostes, R. C. (2014) · Life Sciences · doi:10.1016/j.lfs.2013.12.216 · Cited by 25
Piwkowska, A., Rogacka, D., Jankowski, M., & Angielski, S. (2013) · Acta Biochimica Polonica · doi:10.18388/abp.2013_2028 · Cited by 25
Exceptionally High Proton and Lithium Cation Gas-Phase Basicity of the Anti-Diabetic Drug Metformin
Raczyńska, E. D., Gal, J., Maria, P., Michalec, P., & Zalewski, M. (2017) · The Journal of Physical Chemistry A · doi:10.1021/acs.jpca.7b09338 · Cited by 23
PlGF signaling and macrophage repolarization contribute to the anti-neoplastic effect of metformin
Ma, Q., Gu, J., Wang, B., Feng, J., Yang, L., Kang, X.-W., Duan, P., Sun, X., Liu, P., & Wang, J. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172696 · Cited by 24
Bouras, H., Roig, S. R., Kurstjens, S., Tack, C. J., Kebieche, M., de Baaij, J. H. F., & Hoenderop, J. G. J. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0570 · Cited by 26
Emerging medical treatments for hidradenitis suppurativa
Lyons, A. B., Shabeeb, N., Nicholson, C. L., Braunberger, T. L., Peacock, A., & Hamzavi, I. H. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.04.009 · Cited by 23
Kim, Y., Kim, H.-S., Lee, J., Kim, Y.-S., You, H., Bae, Y., Lee, H.-C., Han, Y.-E., Choi, E.-A., Kim, J., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108496 · Cited by 23
Zhao, J., & Xu, Q. (2022) · Frontiers in Marine Science · doi:10.3389/fmars.2022.844716 · Cited by 23
Thymic emigration patterns in patients with type 2 diabetes treated with metformin
Dworacki, G., Urazayev, O., Bekmukhambetov, Y., Iskakova, S., Frycz, B. A., Jagodziński, P. P., & Dworacka, M. (2015) · Immunology · doi:10.1111/imm.12522 · Cited by 23
Bowdridge, E. C., Goravanahally, M. P., Inskeep, E. K., & Flores, J. A. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.115.129411 · Cited by 24
Role of Tissue and Systemic Hypoxia in Obesity and Type 2 Diabetes
Xi, L., Chow, C. M., & Kong, X. (2016) · Journal of Diabetes Research · doi:10.1155/2016/1527852 · Cited by 23
Macha, S., Brand, T., Meinicke, T. W., Link, J., & Broedl, U. C. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.06.003 · Cited by 25
Current and Emerging Treatment Options in Diabetes Care
Clemmensen, C., Müller, T. D., Finan, B., Tschöp, M. H., & DiMarchi, R. D. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_7 · Cited by 23
Machado, A. D. B., dos Reis, V. M. S. F., Weber, S. F., Jauckus, J., Brum, I. S., Corleta, H. V. E., Strowitzki, T., Capp, E., & Germeyer, A. (2016) · Oncology Letters · doi:10.3892/ol.2016.5041 · Cited by 23
Metformin and Colorectal Cancer – A Systematic Review.
Kobiela, J., Dobrzycka, M., Jędrusik, P., Kobiela, P., Spychalski, P., Śledziński, Z., & Zdrojewski, T. R. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0621-8830 · Cited by 24
Cholinergic and metabolic effects of metformin in mouse brain
Thinnes, A., Westenberger, M., Piechotta, C., Lehto, A., Wirth, F., Lau, H., & Klein, J. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.02.018 · Cited by 24
Metformin derivatives – Researchers’ friends or foes?
Torunoglu, S. T., Zajda, A., Tampio, J., Markowicz-Piasecka, M., & Huttunen, K. M. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115743 · Cited by 23
A Longitudinal HbA1c Model Elucidates Genes Linked to Disease Progression on Metformin
Goswami, S., Yee, S. W., Xu, F., Sridhar, S., Mosley, J. D., Takahashi, A., Kubo, M., Maeda, S., Davis, R., Roden, D. M., et al. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.428 · Cited by 23
Zakłos‐Szyda, M., & Pietrzyk, N. (2018) · Acta Biochimica Polonica · doi:10.18388/abp.2017_1604 · Cited by 22
Rashwan, A. S., El-Beltagy, M. A., Saleh, S. Y., & Ibrahim, I. A. (2019) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-019-0025-9 · Cited by 22
Valdés, M., Calzada, F., Mendieta‐Wejebe, J. E., Merlin-Lucas, V. I., Velázquez, C., & Barbosa, E. (2020) · Molecules · doi:10.3390/molecules25153361 · Cited by 24
Rule-based multi-scale simulation for drug effect pathway analysis
Hwang, W., Hwang, Y., Lee, S., & Lee, D. (2013) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-13-s1-s4 · Cited by 22
Su, K., & Dai, C. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2291-1 · Cited by 23
Glucose plus metformin compared with glucose alone on β-cell function in mouse pancreatic islets
HASHEMITABAR, M., BAHRAMZADEH, S., SAREMY, S., & NEJADDEHBASHI, F. (2015) · Biomedical Reports · doi:10.3892/br.2015.476 · Cited by 21
“The positive effects of metformin on insulin receptor expression and tyrosine kinase activity could be improving the insulin sensitivity (6,7).”
Metadata
- Authors
- Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F.
- Affiliations
- INSERM, U1016, Institut Cochin, Paris, France
- Leiden University Medical Center (NL)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Leclerc, Jocelyne
- Foretz, Marc
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2011-11-11
- Volume
- 122
- Issue
- 6
- Pages
- 253-270
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- PMC
- PMC3398862
- OpenAlex
- W2154024784
- Cited by
- 1,720
- References
- 167
- Citations by year
- 2026: 63 · 2025: 85 · 2024: 96 · 2023: 103 · 2022: 106 · 2021: 143 · 2020: 155 · 2019: 135 · 2018: 141 · 2017: 156 · 2016: 137 · 2015: 144 · 2014: 117 · 2013: 104 · 2012: 34
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Keywords
- metformin, type 2 diabetes, biguanides, AMPK, mitochondrial complex I inhibition, hepatic gluconeogenesis, hepatic glucose production, polycystic ovary syndrome, hepatic steatosis, diabetes complications, adjuvant cancer therapy, gestational diabetes mellitus, prediabetes, pharmacogenetics, personalized medicine
- MeSH terms
- Animals, Cardiovascular System, Diabetic Nephropathies, Female, Humans, Hypoglycemic Agents, Metformin, Neoplasms, Polycystic Ovary Syndrome, Circadian Clocks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.